Serinus Biosciences
YC S22New York City, US · Founded 2022 · 6 employees · 3 known investors
Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.
Also known as Serinus
Founders & leadership· Y Combinator alumni (S22)
Serinus Biosciences was founded in 2022 by Adam Yaari and Maxwell Sherman.
AY
Adam Yaariin𝕏Co-founder · Chair of the Board of DirectorsAdam Yaari holds a PhD and MS in computer science from MIT, an MSc in computer science and mathematics from the Weizmann Institute of Science, and a BSc in computer science and neuroscience from Bar-Ilan University. He brings over a decade of entrepreneurial experience, including roles as a Microsoft R&D Fellow and Flagship Pioneering Ideation Fellow, and founded Serinus Biosciences to develop AI models for biological research.
MS
Maxwell Shermanin𝕏Co-founder & CTOMaxwell Sherman worked as a paramedic for five years before pursuing advanced studies in applied mathematics and biology at Brown University, statistics at Cambridge University, and computational biology at MIT, where he completed a PhD. His research has been published in major peer-reviewed journals.
Investors · 3
Competitors · 5
by search overlapSeran Bioscience7 shared keywordsSerán Bioscience is a contract development and manufacturing organization (CDMO) offering drug development, formulation, and clinical manufacturing services to pharmaceutical and biotechnology companies. It provides technologies such as spray drying, hot melt extrusion, and solid dosage form production to support compounds from pre-clinical development through commercial-scale manufacturing.
Precision BioSciences5 shared keywordsPrecision BioSciences develops gene-editing medicines using its proprietary ARCUS genome editing platform, which employs sequence-specific nuclease enzymes to insert, remove, or repair DNA in living cells to treat hard-to-treat conditions including rare genetic diseases and hepatitis B (HBV).
Talus Bio5 shared keywordsTalus develops a proprietary platform that measures and modulates the regulome—the body's gene expression control system—in native cellular contexts. The company designs AI-driven compounds and uses functional proteomics to enable drug discovery for transcription factors and regulatory proteins implicated in oncology, rare disease, and immune dysfunction.
Seres Therapeutics4 shared keywordsSeres Therapeutics is a clinical-stage biotechnology company developing therapies composed of rationally selected live bacterial consortia to treat serious diseases through modulation of the human microbiome. The company pioneered the development and FDA approval of VOWST, an oral live biotherapeutic.
Serinuslabs4 shared keywordsSerinus Labs develops ultra-low power gas sensors using proprietary technology that can detect multiple gases at trace levels simultaneously. The sensors target applications in electric mobility, atmospheric monitoring, and energy storage and distribution.
Companies competing with Serinus Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
In the news
Frequently asked questions
- What does Serinus Biosciences do?
- Serinus Biosciences uses AI and systems biology to design drug combinations that overcome cancer cells' resistance to existing treatments, targeting safer and more effective therapeutic options.
- Who founded Serinus Biosciences?
- Serinus Biosciences was founded by Adam Yaari, Maxwell Sherman in 2022.
- Who are Serinus Biosciences's investors?
- Serinus Biosciences's investors include Illumina Ventures, Metaplanet, Y Combinator.
- Where is Serinus Biosciences headquartered?
- Serinus Biosciences is headquartered in New York City, US.